Lamictal for Depression: Where It May Help—and What to Know
A clear, hopeful guide to lamotrigine: its established role in bipolar care, what researchers are exploring for unipolar depression, and the safety details to discuss with a prescriber.

In this article
When depression persists, it can be encouraging to learn that treatment is not one-size-fits-all. Lamotrigine—often known by the brand name Lamictal—has an important role in bipolar care, and clinicians sometimes consider it in other situations. The evidence and the safety considerations depend on the diagnosis, so here is a grounded place to start.
What lamotrigine is—and what it is approved to treat
Lamotrigine is an antiseizure medicine that is also used as a mood stabilizer. In the United States, the FDA-approved psychiatric indication for Lamictal is maintenance treatment of bipolar I disorder in adults, to help delay future mood episodes after an acute episode has been treated. The label does not establish it as a rapid treatment for an ongoing depressive episode or as an approved treatment for unipolar major depression.¹
That distinction does not mean there are no other possibilities. Clinical guidelines include lamotrigine among medication options for bipolar depression, while its use for unipolar depression is off-label and supported by a more mixed research base.²
What the evidence suggests about depression
For bipolar depression, lamotrigine may be a useful option for some people, particularly when the broader treatment goal includes preventing future depressive episodes. Its place in a treatment plan depends on the person’s symptoms, history, preferences, and other health factors; a clinician can explain how it compares with alternatives.²
For major depression without bipolar disorder, some clinicians consider lamotrigine as an add-on after other treatments have not helped enough. A 2019 meta-analysis of eight randomized trials found an overall positive signal, but results were not consistent across regions: the pooled non-Chinese trials did not show a statistically significant benefit. A large earlier placebo-controlled trial also did not find a significant difference on its primary outcomes.³⁻⁴
So there is a reason for careful discussion—not a guarantee. If your prescriber raises lamotrigine, useful questions include what treatment goal they have in mind, what evidence applies to your situation, how progress will be reviewed, and what other options remain available.
Why it takes time to adjust
Lamotrigine is usually introduced gradually. Slow dose increases are an important safety measure because starting too high or increasing too quickly can raise the risk of a serious rash. The schedule is individualized, and other medicines—including valproate and some hormonal contraceptives—can affect dosing or lamotrigine levels.¹
For that reason, this article does not give a personal dose schedule. Follow the plan from your prescriber, and check before restarting after an interruption; depending on how long you have been off it, the medicine may need to be titrated again.
Side effects and the rash warning
More common effects can include dizziness, headache, blurred or double vision, nausea, and sleepiness. People’s experiences vary, and a prescriber or pharmacist can help distinguish expected effects from symptoms that need attention.¹
Rarely, lamotrigine can cause a severe, potentially life-threatening skin reaction, including Stevens–Johnson syndrome. Risk is higher with valproate, an excessive starting dose, or faster-than-recommended increases, though serious reactions can occur without these factors. Contact a clinician promptly about any new rash while taking lamotrigine; seek urgent care for a rash with blistering, peeling, sores in the mouth or eyes, facial swelling, or feeling very unwell.¹
Do not stop, restart, or change the dose on your own. If you have a concerning symptom, contact your prescriber or urgent medical service for advice tailored to you.
What to discuss with your prescriber
Before starting, share your full medication and supplement list, past medication reactions, and any history of rash. Mention pregnancy plans, hormonal contraception, and conditions that could affect treatment. If you are being treated for depression, tell your clinician about any history of unusually elevated energy or reduced need for sleep, since clarifying whether bipolar-spectrum symptoms are present can change which options make sense.
Agree on a practical follow-up plan: when to check in, what changes you hope to notice, which side effects should prompt a call, and what to do if you miss doses. If symptoms worsen or you feel unsafe, reach out to your care team promptly or use local emergency or crisis support.
The takeaway
Lamotrigine is an established maintenance option for bipolar I disorder and is included in professional guidance for bipolar depression. For unipolar depression, it may be considered off-label in selected cases, but research is mixed and does not make it a dependable fit for everyone.¹⁻⁴
If it comes up in your care, you do not have to decide from an article alone. A thoughtful conversation with a qualified prescriber can clarify the potential benefits, the slow titration and rash precautions, and the other treatment paths still open to you.
References
- [1] DailyMed. Lamictal (lamotrigine): U.S. prescribing information and medication guide.
- [2] Keramatian K, Chithra NK, Yatham LN. The CANMAT and ISBD Guidelines for the Treatment of Bipolar Disorder: Summary and a 2023 Update of Evidence.
- [3] Goh KK, Chen CH, Chiu YH, Lu ML. Lamotrigine augmentation in treatment-resistant unipolar depression: a comprehensive meta-analysis of efficacy and safety (2019).
- [4] Barbee JG, Thompson TR, Jamhour NJ, et al. Placebo-controlled trial of lamotrigine augmentation in treatment-refractory unipolar depression (2011).
